West Coast Summit: The Transformative Power of AI in Pharmaceutical R&D

As we strive to harness the potential of artificial intelligence (AI) to bring new hope to waiting patients, Johnson & Johnson and California Life Sciences have joined forces to produce our West Coast Summit: The Transformative Power of AI in Pharmaceutical R&D.

Join us at One Tower Place in South San Francisco on October 3, 2024 as we convene expert perspectives from the pharmaceutical industry, the startup world and the investor community – focused on how AI is driving the discovery, development and delivery of innovative medicines today, and what the future holds in this rapidly-evolving space.

In addition to this thought-provoking discussion, there will be plenty of opportunities for connecting and collaborating during coffee breaks, lunch and an afternoon networking reception, combined with spotlight presentations highlighting breakthrough innovators in the AI space.

REGISTER»

Agenda

9:00am | Networking & Registration

9:30-9:40am | Welcome Remarks

• Stacy Feld, Regional Head, Johnson & Johnson Innovation West North America

9:40-10:15am | Keynote Speaker

Deep dive into the promise and challenges of AI for pharmaceutical R&D including how we can accelerate innovation to improve patient outcomes.

• Tina Hernandez-Boussard, PhD MPH, Associate Dean of Research and Professor of Medicine (Biomedical Informatics), Biomedical Data Sciences, Surgery and Epidemiology & Population Health (by courtesy), Stanford University

10:15-10:30am | Break

10:30-11:15am | Panel Discussion: Decoding Drug Discovery

Experts will discuss AI’s role in accelerating drug discovery, optimizing molecular design, and predicting drug efficacy and safety, while sharing insights on current applications and future potential.

• Hilary Eaton, PhD, Chief Business Officer, Profluent
• Zhaoshi Jiang, MD, PhD, Former President, BioMap
• Jim Martineau, MBA, Co-Founder & CEO, Nosis Bio (moderator)
• Justin Scheer, PhD, Vice President, In Silico Discovery, Johnson & Johnson Innovative Medicine
• Amoolya Singh, PhD, Senior Vice President of Research & Chief Scientific Officer, GRAIL
• Eeshit Dhaval Vaishnav, PhD, Founder & CEO, Sequome

11:15am-12:00pm | Panel Discussion: Developing Clinical Stage Tools

Our expert panel will reveal how cutting-edge AI tools are reducing drug development timelines and unveiling new possibilities in clinical trials and regulatory filings.

• Saurabh Gombar, MD PhD, Chief Medical Officer & Co-Founder, Atropos Health
• Tripthi Kamath, PhD, Vice President, Immunology, R&D Data Science & Digital Health, Innovative Medicine, Johnson & Johnson
• Deepa Lalla, PhD, Vice President, Evidence Generation, Publications and Partnerships, AstraZeneca
• Mark Lee, MD PhD, Chief Executive Officer & Co-Founder, N-Power Medicine (moderator)
• Anita Gupta Modi, MBA, Chief Executive Officer & Co-Founder, Peer AI

12:00-1:00pm | Lunch & Networking

1:00-1:10pm | The JJI Difference

• Chris Haskell, PhD, Head, JLABS San Francisco Bay Area, Johnson & Johnson

1:10-2:00pm | Roundtable Discussion: The Investor Perspective

A conversation on the investment landscape in AI for Pharma R&D. Our panel will discuss how partnership is key to unlocking the full potential of these technologies

• Vasudev (Vas) Bailey, PhD, Managing Partner, ARTIS Ventures
• Ekaterine (Eka) Kortkhonjia, PhD, Senior Director, Early Innovation Partnering, Johnson & Johnson (moderator)
• Lynne Chou O’Keefe, MBA, Founder & Managing Partner, Define Ventures
• Ruchita Sinha, General Partner, AV8 Ventures
• Qing Zhang, MD MBA, Partner, LDV Partners

2:00-2:15pm | Break

2:15-3:15pm | QuickFire Challenge Finalist Spotlights

• Ability Biologics | Lindsay Blore, MBA, Director Program Management
• Modicus Prime | Taylor Chartier, PhD, Chief Executive Officer, & David Vardanyan, Director of Engineering
• Precision Life | Rowan Gardner, Co-Founder & Chief Business & Investment Officer
• Synlico | Jingwei (Gavin) Lu, PhD, Founder & Chief Executive Officer
• ThinkingNode | Jake Lesnik, Chief Business Officer

3:15-3:55pm | Closing Keynote

• Stacie Calad-Thomson, PhD, Business Development Lead, Healthcare and Life Sciences, NVIDIA

3:55-4:00pm | Closing Remarks

• Dave Apfel, MBA, Head, External Innovation, R&D Data Science & Digital Health, Johnson & Johnson Innovative Medicine
• Mike Guerra, President & Chief Executive Officer, California Life Sciences

4:00-5:00pm | Networking Reception

Thank you to our sponsors:

Tickets:

CLS Members – $25

Non-member life sciences company employee – $50

Non-member service provider company employee – $150